A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18–26 years
C Giambi, S Donati, F Carozzi, S Salmaso… - BMC infectious …, 2013 - Springer
Background Pre-vaccination information on HPV type-specific prevalence in target
populations is essential for designing and monitoring immunization strategies for cervical …
populations is essential for designing and monitoring immunization strategies for cervical …
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition …
LE Markowitz, S Hariri, C Lin, EF Dunne… - The Journal of …, 2013 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination was introduced into the routine
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: a randomized, placebo-controlled trial with …
L Wei, X Xie, J Liu, Y Zhao, W Chen, C Zhao, S Wang… - Vaccine, 2019 - Elsevier
Background A quadrivalent human papillomavirus vaccine (qHPV; HPV6/11/16/18) has
demonstrated efficacy and effectiveness worldwide. We report qHPV vaccine efficacy for up …
demonstrated efficacy and effectiveness worldwide. We report qHPV vaccine efficacy for up …
Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
A Tozawa-Ono, M Kamada, K Teramoto… - Human Vaccines & …, 2021 - Taylor & Francis
In Japan, government support for human papillomavirus (HPV) vaccination began in
November 2010. However, the mass media repeatedly reported on severe adverse events …
November 2010. However, the mass media repeatedly reported on severe adverse events …
Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study
R Konno, S Tamura, K Dobbelaere… - Cancer science, 2011 - Wiley Online Library
Efficacy, immunogenicity and tolerability of the human papillomavirus (HPV)‐16/18 AS04‐
adjuvanted vaccine were evaluated in Japanese women aged 20–25 years, for which …
adjuvanted vaccine were evaluated in Japanese women aged 20–25 years, for which …
Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
D Rosillon, L Baril… - Cancer …, 2019 - Wiley Online Library
Background Infections with human papillomavirus (HPV) types 16 and 18 account for~ 70%
of invasive cervical cancers but the degree of protection from naturally acquired anti‐HPV …
of invasive cervical cancers but the degree of protection from naturally acquired anti‐HPV …
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica
S Coseo, C Porras, A Hildesheim… - Sexually transmitted …, 2010 - journals.lww.com
Background: Serological indicators of human papillomavirus (HPV) infection are being used
to differentiate HPV-naïve from previously infected women in vaccine and …
to differentiate HPV-naïve from previously infected women in vaccine and …
Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
M Onuki, K Yamamoto, H Yahata, H Kanao… - Cancer …, 2022 - Wiley Online Library
Abstract In Japan, the National Immunization Program against human papillomavirus (HPV)
targets girls aged 12‐16 years, and catch‐up vaccination is recommended for young women …
targets girls aged 12‐16 years, and catch‐up vaccination is recommended for young women …
Multi-infection patterns and co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across China
G Liao, X Jiang, B She, H Tang, Z Wang, H Zhou… - Frontiers in …, 2020 - frontiersin.org
Background: The epidemiological feature of human papillomavirus (HPV) infection is
distinctive in China. We aimed to investigate the multi-infection patterns and co-infection …
distinctive in China. We aimed to investigate the multi-infection patterns and co-infection …
[HTML][HTML] Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario
GY Lee, P Inthasorn, P Laowahutanont, S Lawpoolsri… - Vaccine, 2022 - Elsevier
Objective This study aimed to determine the real-world effectiveness of bi-or quadrivalent
human papillomavirus (HPV) vaccines in Thai adult women≥ 5 years post-vaccination in …
human papillomavirus (HPV) vaccines in Thai adult women≥ 5 years post-vaccination in …